Haemonetics shares reach their highest price in a year after CSL Plasma plans to use its devices nationwide.

Oct 8, 2026, 1:30 PM ETDealRead the original at Benzinga

Good for HAE

CSL expects to move all its U.S. centers to Haemonetics’ devices and disposable products, which could grow sales. The schedule and purchase amounts are unsettled, so the size and timing of the benefit are uncertain.

HAE · Haemonetics Corporation

AI read · Good for HAE

The AI's read

That could create more repeat sales from disposable products, not just device placements. CSL has not settled every deployment detail, and actual sales depend on purchase volumes and Haemonetics’ ability to supply products. Haemonetics kept its fiscal 2027 forecast unchanged and plans to explain the possible financial effect in November 2026.

Get alerts for HAE

Follow Haemonetics Corporation (HAE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HAE

Free on the App Store and Google Play, or on the web.